Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 586 to 600 of 735 results for adult social

  1. Cannabidiol with clobazam for treating seizures associated with Lennox–Gastaut syndrome (TA615)

    Evidence-based recommendations on cannabidiol (Epidyolex) with clobazam for seizures associated with Lennox–Gastaut syndrome in people aged 2 years and older.

  2. What is the clinical and cost effectiveness of cognitive rehabilitation for people with Multiple sclerosis (MS)?

    activities. People with MS who have cognitive problems often engage in fewer social and vocational activities, are less likely to be in...

  3. Atezolizumab in combination with platinum-based chemotherapy for untreated locally advanced or metastatic urothelial cancer [ID1206]

    Discontinued Reference number: GID-TA10202

  4. Supporting young people to manage their conditions:- What is the relationship between transition and subsequent self-management?

    from guidance Transition from children's to adults' services for young people using health or social care services Number...

  5. Fruquintinib for previously treated metastatic colorectal cancer (TA1079)

    Evidence-based recommendations on fruquintinib (Fruzaqla) for previously treated metastatic colorectal cancer in adults.

  6. Aquilion PRIME CT scanner for imaging coronary artery disease in adults in whom imaging is difficult (MIB53)

    NICE has developed a medtech innovation briefing (MIB) on the Aquilion PRIME CT scanner for imaging coronary artery disease in adults in whom imaging is difficult .

  7. Somatom Definition Edge CT scanner for imaging coronary artery disease in adults in whom imaging is difficult (MIB54)

    NICE has developed a medtech innovation briefing (MIB) on the Somatom Definition Edge CT scanner for imaging coronary artery disease in adults in whom imaging is difficult .

  8. Molnupiravir for treating COVID-19 (TA1056)

    Evidence-based recommendations on molnupiravir (Lagevrio) for treating mild to moderate COVID-19 in adults who have a positive SARS-CoV-2 test.

  9. Care pathway:- In the UK, what is the optimal care pathway for young people and adults with coexisting severe mental illness and substance misuse?

    pathway:- In the UK, what is the optimal care pathway for young people and adults with coexisting severe mental illness and substance...

  10. What are the key factors, including additional care and support, that influence participation* and quality of life in people with neuropathic pain?

    interpersonal interactions and relationships, major life areas, community, and social and civil life. There is evidence suggesting that...

  11. Refractory [Irritable bowel syndrome] (IBS):- What factors contribute to refractory IBS?

    profile, psychological symptoms, childhood adversity, psychiatric history, social supports, quality of life and other relevant potential...

  12. Isatuximab with pomalidomide and dexamethasone for treating relapsed and refractory multiple myeloma (TA658)

    Evidence-based recommendations on isatuximab (Sarclisa) with pomalidomide and dexamethasone for treating relapsed and refractory multiple myeloma in adults.

  13. Barriers and facilitators:- What are the barriers and facilitators for young people and adults with coexisting severe mental illness and substance misuse to obtain an optimal service (including optimal time frame for delivering interventions) to meet their needs and enable their recovery?

    facilitators:- What are the barriers and facilitators for young people and adults with coexisting severe mental illness and substance...

  14. Team composition for home-based intermediate care:- How effective and cost effective are different approaches, in terms of team structure and composition, to providing home-based intermediate care for adults?

    structure and composition, to providing home-based intermediate care for adults? Any explanatory notes(if applicable) Why this is...

  15. How cost effective are fluoride varnish programmes and tooth-brushing schemes?

    outcomes should include the use of non-dental health and social care services by children and adults, such as numbers...